JAML is a novel immunotherapy target for tissue-resident memory T cells [scRNA-seq]
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
Tumor-infiltrating CD8+ T cells express high levels of the co-stimulatory molecule JAML, which can be exploited for cancer immunotherapy. Single-cell RNA-seq was performed from CD45+JAML+ T cells isolatied from murine tumor (n = 3)
创建时间：
2023-08-08
